ebm:effect_estimation
Differences
This shows you the differences between two versions of the page.
| Next revision | Previous revision | ||
| ebm:effect_estimation [2020/07/20 01:03] – created dhawann | ebm:effect_estimation [2020/07/20 01:40] (current) – [Odds ratio] dhawann | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| - | < | + | < |
| - | <h1 id="effect-estimation">Effect Estimation</h1> | + | <script |
| - | <h2 id="odds-ratio">Odds ratio</h2> | + | |
| - | <ul> | + | ====== Effect Estimation ====== |
| - | < | + | |
| - | <li>Odds are defined as <span class=" | + | ===== Odds ratio ===== |
| - | < | + | |
| - | <li>if the probability is 50% then it's $ which is 50-50.</li> | + | * Odds ration makes regression analysis |
| - | </ | + | |
| - | </ | + | |
| - | <h2 id=" | + | |
| - | <ul> | + | ===== Relative ratio ===== |
| - | <li>Or it can be a relative risk: the likelihood of responding if given</li> | + | |
| - | </ul> | + | |
| - | <p>treatment would be <span class=" | + | |
| - | <h2 id=" | + | treatment would be $$\frac{a}{a+b}.$$ So the relative likelihood of responding if given the treatment would be $$\frac{c}{c+d}.$$ So the relative likelihood of responding if given the treatment would be $$\frac{\frac{a}{a+b}}{\frac{c}{c+d}}$$ |
| - | <ul> | + | |
| - | <li>People use the term effect size to mean standardized effect size.</li> | + | ===== Effect size ===== |
| - | <li>The standardized effect size, called | + | |
| - | </ | + | |
| - | <p>described above (such as a mean number) divided by the standard deviation (the measure of variability).</p> | + | |
| - | < | + | |
| - | <li>Cohen' | + | |
| - | <li>0.4 or lower is small effect size</li> | + | |
| - | <li>0.4 to 0.7 is medium effect size</li> | + | |
| - | <li>greater than 0.7 is large effect size</li> | + | |
| - | <li>Nonetheless, | + | |
| - | </ul> | + | ===== Number Needed to Treat and Number Needed to Harm ===== |
| - | <h2 id="nnt-and-nnh"> | + | |
| - | <h3 id=" | + | ==== Formula ==== |
| - | <ul> | + | |
| - | <li>Number needed to treat or harm is 1 divided by the absolute risk reduction or risk increase.</li> | + | |
| - | <li>example: If 50% of people responded to a drug and 30% responded to placebo the</ | + | |
| - | </ | + | |
| - | <p>absolute risk reduction would be 20%. The number needed to treat would be 1/0.2 which is 5.</p> | + | ==== NNT ==== |
| - | <h3 id=" | + | |
| - | <ul> | + | |
| - | <li>NNT of 5 or less is very large.</li> | + | |
| - | <li>NNT of 5-10 is large.</li> | + | |
| - | <li>NNT of 10-20 is medium.</li> | + | |
| - | <li>NNT of 20-50 is small.</li> | + | |
| - | <li>NNT of greater than 50 is very small.</li> | + | |
| - | </ul> | + | ==== NNH ==== |
| - | <h3 id=" | + | |
| - | <ul> | + | |
| - | <li>NNH is used to determine side effects.</li> | + | |
| - | <li>formula is the same as NNT.</li> | + | |
| - | </ul> | + | ===== Confidence intervals |
| - | <h2 id=" | + | |
| - | <ul> | + | |
| - | <li>Jerzy Neyman who created hypothesis testing also advanced confidence intervals approach.</li> | + | |
| - | <li>Rather Neyman saw it as a conceptual construct that helped us appreciate how well our observations have approached reality. As Salsburg puts it: ¡°the | + | |
| - | </ | + | |
| - | <p>interval has to be viewed not in terms of each conclusion but as a process. In the long run, the statistician who always computes 95 percent confdence intervals will fnd that the true value of the parameter lies within the computed interval 95 percent of the time. Note that, to Neyman, the probability associated with the confdence interval was not the probability that we are correct. It was the frequency of correct statements that a statistician who uses his method will make in the long run. It says nothing about how ¡®accurate¡¯ | + | |
| - | <ul> | + | ===== Cohort studies ===== |
| - | <li>"The CI uses mathematical formulae similar to what are used to calculate p-values (each extreme is computed at 1.96 standard deviations from the mean in a normal distribution), | + | |
| - | </ul> | + | * prospective is better. Framingham and STEP-BD are good prospective cohorts. |
| - | </html> | + | * STEP-BD cost 20 million dollars |
| + | |||
| + | ==== Retrospective cohort studies ==== | ||
| + | |||
| + | * cheap and can be very useful, but has limitations. | ||
| + | |||
| + | < | ||
| + | < | ||
| + | < | ||
| + | < | ||
| + | < | ||
| + | < | ||
ebm/effect_estimation.1595206982.txt.gz · Last modified: 2020/07/20 01:03 by dhawann